Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacogenomics Public Workshop Planned For April 2005

This article was originally published in The Pink Sheet Daily

Executive Summary

The meeting will follow release of an FDA draft guidance on the co-development of pharmacogenomic tests with a drug or biologic, which is expected by the end of the year.

You may also be interested in...



FDA Pharmacogenomic Submissions Final Guidance To Be Issued In March

The guidance has cleared the agency's Office of the Chief Counsel, FDA's Lawrence Lesko tells the Drug Information Association meeting in Lisbon, Portugal. FDA will launch a pharmacogenomics website the week of March 14 that will include information on "what's going on with voluntary submissions," Lesko says.

FDA Pharmacogenomic Submissions Final Guidance To Be Issued In March

The guidance has cleared the agency's Office of the Chief Counsel, FDA's Lawrence Lesko tells the Drug Information Association meeting in Lisbon, Portugal. FDA will launch a pharmacogenomics website the week of March 14 that will include information on "what's going on with voluntary submissions," Lesko says.

FDA Names Frueh Head Of Pharmacogenomics Review Group

Felix Frueh, PhD, is associate director of genomics in CDER’s Office of Clinical Pharmacology & Biopharmaceutics and head of FDA’s new Interdisciplinary Pharmacogenomics Review Group. The agency continues to recruit staff for the IPRG.

Related Content

Topics

UsernamePublicRestriction

Register

PS057845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel